Mucosal Vaccines

Most infectious agents enter the body at mucosal surfaces and therefore mucosal immune responses function as a first line of defence. Protective mucosal immune responses are most effectively induced by mucosal immunization through oral, nasal, rectal or vaginal routes, but the vast majority of vaccines in use today are administered by injection. Immunisation involves the delivery of antigens to the mucosal immune system (dispersed or organised into units such as Peyer’s patches in the intestine or the nasal-associated lymphoid tissue in the oropharangeal cavity). The antigen delivery systems may comprise a simple buffer solution with/without adjuvants or an advanced particulate formulation, such as liposomes or nanoparticles. The most commonly evaluated route for mucosal antigen delivery is oral, but other routes have also been explored.

  • Edible Vaccines
  • Common vaccinations given by mucosal route
  • Mucosal Vaccines Delivery
  • Challenges in mucosal vaccine design
  • Mucosal vaccine development

Related Conference of Mucosal Vaccines

July 27-28, 2017

International Vaccines Congress

Chicago, USA
August 21-22, 2017

17th International Conference on Children Vaccines

Birmingham, UK
September 18-19, 2017

20th Global Summit & Expo on Vaccines & Immunization

(10 Plenary Forums-1Event) Houston, USA
July 27-28, 2017

19th International Vaccines Congress

Chicago, USA
October 05-07, 2017

World Vaccines and Immunization Congress

Osaka, Japan
November 30-December 01, 2017

23rd Global Vaccines & Vaccination Summit

Dubai, UAE

Mucosal Vaccines Conference Speakers

Recommended Sessions

Related Journals

Are you interested in